维普期刊资源整合服务平台（V6.5）

52篇 您的检索式：作者名="YARDLEY DA"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Phase H study of neoadjuvant weekly nab-paelitaxel and carboplatin, with bevaci- zumab and trastuzumab, as treatment for women with locally ad- vanced HER2 + breast cancer显示文摘	Yardley DA Raefsky E Castillo R	2011	Clin Breast Cancer2011，11，5：	1
2	Updates in the treatment of basal/triplenegative breast cancer显示文摘	Shastry M Yardley DA	2013	Cur Opin Obst Gyne2013，25，1：	1
3	Activity of ixabepilone in patients with metastatic breast cancer with primary resistance to taxanes显示文摘	Yardley DA	2008	Clin Breast Cancer2008，8，6：	1
4	Weekly doeetaxel in the treatment of elderly patients with advanced breast cancer 显示文摘	Hainsworth JD Burris HA 3rd Yardley DA	2001	J Clin Oncol2001，19，15：	1
5	A phase lI trial of gemcitabine/carboplatin with or without trastuzumab in the first- line treatment of patients with metastatic breast cancer显示文摘	Yardley DA Burris HA 3rd Simons L	2008	Clin Breast Cancer2008，8，5：	1
6	Regist HER: patient characteristics and time course of CNS metastases in patients with HER2-positive metastatic breast cancer显示文摘	Yardley DA Kaufman PA Mayer M	2007	Breast Cancer Res Treat2007，106，26：	1
7	Everolimus plus exemestane in postmenopausal patients with HR(+) breast cancer: BOLERO-2 final progression-free survival analysis显示文摘	Yardley DA Noguchi S Pritchard KI	2013	Adv Ther2013，30，10：	1
8	Weekly docetaxel in the treatment of elderly patients with advanced breast cancer: a Minnie Pearl Cancer Research Network phase Ⅱ trial 显示文摘	Hainsworth JD Burris HA 3rd Yardley DA	2001	J Clin Oncol2001，19，15：	1
9	Phase II study ofneoadjuvant weekly nab-paclitaxel and carboplatin, withbevacizumab and trastuzumab, as treatment for womenwith locally advanced HER2+ breast cancer显示文摘	Yardley DA Raefsky E Castillo R	2011	Clin BreastCancer2011，115，：	1
10	Everoli- mus plus exemestane in postmenopausal patients with HR ( + ) breast cancer: BOLERO-2 final progression-free survival analysis 显示文摘	YARDLEY DA NOGUCHI S PRITCHARD KI	2013	Adv Ther2013，30，10：	1
11	Activity of ixabepilone in patients with metastatic breast cancer with primary resestance to taxanes显示文摘	Yardley DA	2008	Clin Breast Cancer2008，8，6：	1
12	A phase II trial of gem- citabine/carboplatinwith or without trastuzumab in the first - line treat- ment of patients with metastatic breast cancer显示文摘	Yardley DA Burris HA 3rd Simons L	2008	Clin Breast Canc- er2008，8，5：	1
13	Gemcitabine and docetaxel in metastatic and neo- adiuvant treatment of breast cancer显示文摘	Yardley DA	2004	Semin Oncol2004，31，25：	1
14	A phase II trial of vinflunine as monatherapy or in combination with trastuzumab as first-line treatment of metastatic breast cancer 显示文摘	YARDLEY DA MCCLEOD M SCHREIBER F	2010	Cancer Invest2010，28，9：	1
15	nab-Paclitaxel mechanisms of action and delivery显示文摘	Yardley DA	2013	J Control Release2013，170，3：	1
16	nab-Paclitaxel mechanisms of action and delivery显示文摘	Yardley DA	2013	J Control Release2013，170，3：	1
17	A phase II trial of gemcitabine/carboplatin with or without trastuzumab in the first-line treatment of patients withmetastatic breast cancer显示文摘	Yardley DA Burris HA 3rd Simons L	2008	Clin Breast Cancer2008，8，5：	1
18	Nab-Paclitaxel mechanisms of action and delivery 显示文摘	Yardley DA	2013	J Control Release2013，，3：	1
19	Long-term survivor characteristics in HER2-positive metastatic breast cancer from reg- istHER 显示文摘	Yardley DA Tripathy D Brufsky AM	2014	Br J Cancer2014，110，11：	1
20	Activity of ixabepilone in patients with metastatic br east cancer with primary resistance to taxanes显示文摘	Yardley DA	2008	Clin Breast Cancer2008，8，6：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示